Skip to main content
Premium Trial:

Request an Annual Quote

Advanced Array Technology, Genomic Solutions

Premium

Advanced Array Technology of Namur, Belgium, has introduced its Rat Hepatochip, a microarray with 51 genes chosen because of their involvement in toxicologically relevant gene pathways, as well as eight housekeeping genes to normalize the data, and three internal standards.

The company (www.aat-array.com) is actively seeking researchers to validate the arrays, according to company spokesman Silvain Margaine.

 

Genomic Solutions of Ann Arbor, Mich., has validated its GeneTAC HybStation, as well as its G3 Library Management System, LS IV, and UC4 instruments, for use in producing and processing protein chips.

“The ability to produce both protein and DNA microarrays extends the utility of our GeneTAC Biochip System and allows researchers to carry out proteomic and genomic research on a common platform,” said Michael Kane, vice president for research and development at Genomic Solutions.

 

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.